Cross-cultural adaptation of the knowledge of disease management-CF-adolescent questionnaire for Brazilian Portuguese

Authors

  • Hilda Angélica Iturriaga Jimenez Universidade Federal de Minas Gerais (UFMG) – Belo Horizonte (MG), Brazil.
  • Luci Fuscaldi Teixeira-Salmela Universidade Federal de Minas Gerais (UFMG) – Belo Horizonte (MG), Brazil.
  • Lívia de Castro Magalhães Universidade Federal de Minas Gerais (UFMG) – Belo Horizonte (MG), Brazil.
  • Marcelo Velloso Universidade Federal de Minas Gerais (UFMG) – Belo Horizonte (MG), Brazil.

DOI:

https://doi.org/10.1590/

Keywords:

Cystic Fibrosis, Patient Health Questionnaire, Knowledge Management, Health Knowledge, Attitudes, Practice

Abstract

This study aimed to cross-culturally adapt
the Knowledge of Disease Management-CF-Adolescent
(KDM-CF-Adolescent) questionnaire for Brazilian
Portuguese, as well as to test its measurement properties.
Cross-cultural adaptation followed five standardized
steps: translation; consensus version of the translation,
back translation, consensus version of back translation,
and application of the final version to 35 adolescent
patients with cystic fibrosis (FC), aged 11 to 20 years. Due
to the COVID-19 pandemic and social isolation measures,
the questionnaire was applied online using the Google
Forms. Data were subjected to Rasch analysis, using the
WINSTEPS software. There were no problems regarding
understanding the questions, so making changes in any
of the translated items was not necessary. The KDMCF-
Adolescent divided the sample into two levels of
knowledge and the items into three levels of difficulty,
leading to person and item reliability indices of 0.67 and
0.81, respectively and internal consistency of 0.69. All
items fit the Rasch model expectations, since all infit/outfit
and associated z-values were within the expected range.
The principal component analysis confirmed the existence
of two dimensions; however, they did not function as
independent scales. There was no duplication of any
content and no floor and/or ceiling effects were found.
The Brazilian Portuguese version of KDM-CF-Adolescent
questionnaire demonstrated satisfactory properties to
measure the knowledge adolescents with CF have about
the disease.

Downloads

Download data is not yet available.

References

1. Cystic Fibrosis Foundations. Patient Registry Annual Report

2019 [Internet]. Maryland: CFF; 2019 [cited 2022 Mar]. Available

from: https://www.cff.org/sites/default/files/2021-10/2019-

Annual-Report.pdf

2. Grupo brasileiro de estudo de fibrose cística. Registro brasileiro

de fibrose cística [Internet]. 2021 [cited 2022 Aug]. Available

from: http://www.gbefc.org.br/ckfinder/userfiles/files/

Relatorio_Rebrafc_2021(1).pdf

3. Pakhale S, Baron J, Armstrong M, Tasca G, Gaudet E, et al.

Lost in translation? How adults living with Cystic Fibrosis

understand treatment recommendations from their health

providers, and the impact on adherence to therapy. Patient

Educ Couns. 2016;99(8):1319-24. doi: 10.1016/j.pec.2016.03.023

4. Ratjen F, Bell SC, Rowe SM, Goss CH, Quittner AL, Bush A.

Cystic fibrosis. Nat Rev Dis Primers. 2015;1:15010. doi: 10.1038/

nrdp.2015.10

5. Chomik S, Klincewicz B, Cichy W. Disease specific knowledge

about cystic fibrosis, patient education and counselling

in Poland. Ann Agric Environ Med. 2014;21(2):420-4. doi:

10.5604/1232-1966.1108617

6. Marciel KK, Saiman L, Quittell LM, Dawkins K, Quittner AL.

Cell phone intervention to improve adherence: cystic fibrosis

care team, patient, and parent perspectives. Pediatr Pulmonol.

2010;45(2):157-64. doi: 10.1002/ppul.21164

7. Machado MFAS, Monteiro EMLM, Queiroz DT, Vieira NFC, Barroso

MGT. Integrality, health professional education, health education

and SUS proposals: a conceptual review. Cien Saude Colet.

2007;12(2):335-42. doi: 10.1590/s1413-81232007000200009

8. Almughem FA, Aldossary AM, Tawfik EA, Alomary MN, Alharbi

WS, et al. Cystic fibrosis: overview of the current development

trends and innovative therapeutic strategies. Pharmaceutics.

2020;12(7):616. doi: 10.3390/pharmaceutics12070616

9. Sawicki GS, Goss, CH. Tackling the increasing complexity of CF

care. Pediatr Pulmonol. 2015;50(S40):S74-S79. doi: 10.1002/

ppul.23244

10. Bartholomew LK, Parcel GS, Seilheimer DK, Czyzewski D,

Spinelli SH, et al. Development of health education program

to promote the self-management of cystic fibrosis. Health

Educ Q. 1991;18(4):429-43. doi: 10.1177/109019819101800403

11. Davis MA, Quittner A, Stack BS, Yang MC. Controlled evaluation

of STARBRIGHT CD-ROM program for children and adolescents

with cystic fibrosis. J Pediatr Psychol. 2004;29(4):259-67. doi:

10.1093/jpepsy/jsh026

12. Quittner AL, Riekert KA, Marciel KK, Kimberg CI, Eakin MN,

et al. Adolescent management of CF: gaps in knowledge

and treatment skills in the iCARE study. Pediatr Pulmonol.

2010;45(S33):199-200. doi: 10.1002/ppul.21338

13. Sawicki GS, Kimberg C, Marciel KK, Riekert K, Zhang J, et

al. An assessment of disease-specific knowledge among

parents of adolescents with cystic fibrosis. Pediatr Pulmonol.

2010;45(S33):438. doi: 10.1002/ppul.21339

14. Kimberg CI, Marciel KK, Riekert KA, Zhang J, Quittner AL.

Knowledge of disease management in adolescents with cystic

fibrosis. Pediatr Pulmonol. 2010;45(S33):447. doi: 10.1002/

ppul.21340

15. Bernstein RM, Riekert KA, Quittner AL. Measuring knowledge of

disease management in adolescents with cystic fibrosis: initial

psychometric evaluation. Pediatr Aller Immunol Pulmonol.

2018;31(2):56-65. doi: 10.1089/ped.2017.0850

16. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines

for the process of cross-cultural adaptation of self-report

measures. Spine (Phila Pa 1976). 2000;25(24):3186-91. doi:

10.1097/00007632-200012150-00014

17. Wild D, Grove A, Martin M, Eremenco S, McElroy S, et al.

Principles of good practice for the translation and cultural

adaptation process for Patient-Reported Outcomes (PRO)

measures: report of the ISPOR task force for translation and

cultural adaptation. Value Health. 2005;8(2):94-104. doi:

10.1111/j.1524-4733.2005.04054.x

18. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation

of health-related quality of life measures: literature review and

proposed guidelines. J Clin Epidemiol. 1993;46(12):1417-32. doi:

10.1016/0895-4356(93)90142-n

19. Tyson S, Connell L. The psychometric properties and clinical

utility of measures of walking and mobility in neurological

conditions: a systematic review. Clin Rehabil. 2009;23(11):1018-

33. doi: 10.1177/0269215509339004

20. Veiga RFN, Morais AF, Nascimento SJN, Avelino PR, Costa HS,

et al. Translation, cross-cultural adaptation and reliability of

the clinical utility scale of Tyson and Connell. Fisioter Pesqui.

2020;27(1):78-84. doi: 10.1590/1809-2950/19006227012020

21. Bond TG, Yan Z, Heene M. Applying the Rasch Model:

fundamental measurement in the human sciences. 4th ed.

New York: Routledge; 2021.

22. Linacre JM. A user’s guide to Winsteps® Ministep Rasch-Model

computer programs: program manual 3.81.0. Chicago: winsteps.

com, ISBN 0-941938-03-4; 2021. [Cited 2021 Nov]. Available

from: http://www.winsteps.com/winman/index.htm

23. Chern JS, Kielhofner G, Gloria de las Heras C, Magalhães LC.

The volitional questionnaire: psychometric development and

practical use. Am J Occup Ther. 1996;50(7):516-25. doi: 10.5014/

ajot.50.7.516

24. Raîche G. Critical eigenvalue sizes in standardized residual

principal component analysis. Rash Measurement Transactions.

2005;19(1):1012. Available from: https://www.rasch.org/rmt/

rmt191.pdf

25. Chien CW, Bond TG. Measurement properties of fine motor

scale of Peabody developmental motor scales-second edition:

a Rasch analysis. Am J Phys Med Rehabil. 2009;88(5):376-86.

doi: 10.1097/phm.0b013e318198a7c9

26. Tennant A, Conaghan PG. The Rasch measurement model

in rheumatology: what is it and why use it? when should it

be applied, and what should one look for in a Rasch paper?

Arthritis Rheum. 2007;57(8):1358-62. doi: 10.1002/art.23108

27. Dumont C, Bertrand R, Fougeyrollas P, Gervais M. Rasch

modeling and the measurement of social participation. J Appl

Meas. 2003;4(4):309-25.

28. Fischer WP. The Rasch Model as a Construct Validation Tool

- Cash value of reliability. Rasch Measurement Transactions.

2008; 22(1):1145-46. Available from: https://www.rasch.org/

rmt/rmt221.pdf

29. Rodrigues SLL, Rodrigues RCM, São-João TM, Pavan RBB,

Padilha KM, el at. Impact of the disease: acceptability, ceiling

and floor effects and reliability of an instrument in heart

failure. Rev Esc Enferm USP. 2013;47(5):1091-8. doi: 10.1590/

s0080-623420130000500012

30. Kazmerski TM, Miller E, Abebe KZ, Matisko J, Schachner D, Spahr

J. Patient knowledge and clinic attendance in adolescent with

cystic fibrosis. Pediatr Aller Immunol Pulmonol. 2015;28(2):107-

11. doi: 10.1089/ped.2014.0475

Downloads

Published

2026-07-20

Issue

Section

Original Research

How to Cite

Cross-cultural adaptation of the knowledge of disease management-CF-adolescent questionnaire for Brazilian Portuguese. (2026). Fisioterapia E Pesquisa, 33(n cont), e24008126. https://doi.org/10.1590/